Lorazepam
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71610-827 -
Package NDC
71610-827-10 -
Package NDC
71610-827-15 -
Package NDC
71610-827-20 -
Package NDC
71610-827-28 -
Package NDC
71610-827-30 -
Package NDC
71610-827-45 -
Package NDC
71610-827-53 -
Package NDC
71610-827-60 -
Package NDC
71610-827-70 -
Package NDC
71610-827-75 -
Package NDC
71610-827-80 -
Package NDC
71610-827-92 -
Application number
ANDA076045 -
SPL ID
334dd50d-b89b-af1b-e063-6294a90ad9bf -
SPL set ID
17919c82-87f2-5030-e063-6294a90ac91a -
UNII
O26FZP769L -
RxCUI
197900
What the source publishes
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Active ingredients
- Lorazepam
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Lorazepam",
"splId": "334dd50d-b89b-af1b-e063-6294a90ad9bf",
"labels": [
{
"setId": "17919c82-87f2-5030-e063-6294a90ac91a",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17919c82-87f2-5030-e063-6294a90ac91a",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=17919c82-87f2-5030-e063-6294a90ac91a"
}
],
"routes": [
"ORAL"
],
"labeler": "Aphena Pharma Solutions - Tennessee, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 TABLET in 1 BOTTLE (71610-827-10)",
"package_ndc": "71610-827-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20240502"
},
{
"sample": false,
"description": "15 TABLET in 1 BOTTLE (71610-827-15)",
"package_ndc": "71610-827-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20240508"
},
{
"sample": false,
"description": "20 TABLET in 1 BOTTLE (71610-827-20)",
"package_ndc": "71610-827-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20240508"
},
{
"sample": false,
"description": "28 TABLET in 1 BOTTLE (71610-827-28)",
"package_ndc": "71610-827-28",
"identifierStatus": "well-formed",
"marketing_start_date": "20240502"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (71610-827-30)",
"package_ndc": "71610-827-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20240502"
},
{
"sample": false,
"description": "45 TABLET in 1 BOTTLE (71610-827-45)",
"package_ndc": "71610-827-45",
"identifierStatus": "well-formed",
"marketing_start_date": "20240502"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (71610-827-53)",
"package_ndc": "71610-827-53",
"identifierStatus": "well-formed",
"marketing_start_date": "20240502"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (71610-827-60)",
"package_ndc": "71610-827-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20240502"
},
{
"sample": false,
"description": "120 TABLET in 1 BOTTLE (71610-827-70)",
"package_ndc": "71610-827-70",
"identifierStatus": "well-formed",
"marketing_start_date": "20240605"
},
{
"sample": false,
"description": "150 TABLET in 1 BOTTLE (71610-827-75)",
"package_ndc": "71610-827-75",
"identifierStatus": "well-formed",
"marketing_start_date": "20250415"
},
{
"sample": false,
"description": "180 TABLET in 1 BOTTLE (71610-827-80)",
"package_ndc": "71610-827-80",
"identifierStatus": "well-formed",
"marketing_start_date": "20240502"
},
{
"sample": false,
"description": "270 TABLET in 1 BOTTLE (71610-827-92)",
"package_ndc": "71610-827-92",
"identifierStatus": "well-formed",
"marketing_start_date": "20240502"
}
],
"productId": "71610-827_334dd50d-b89b-af1b-e063-6294a90ad9bf",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "71610-827",
"deaSchedule": "CIV",
"genericName": "Lorazepam",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LORAZEPAM",
"strength": ".5 mg/1"
}
],
"applicationNumber": "ANDA076045",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20231026",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175694",
"M0002356"
],
"unii": [
"O26FZP769L"
],
"rxcui": [
"197900"
],
"spl_set_id": [
"17919c82-87f2-5030-e063-6294a90ac91a"
],
"pharm_class_cs": [
"Benzodiazepines [CS]"
],
"pharm_class_epc": [
"Benzodiazepine [EPC]"
],
"manufacturer_name": [
"Aphena Pharma Solutions - Tennessee, LLC"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71610-827_334dd50d-b89b-af1b-e063-6294a90ad9bf"